Supply Chain Resilience and Risk Management in FDA-Regulated Industries

  • Wednesday
  • March
  • 25
  • 2026
10:00 AM PDT | 01:00 PM EDT
Duration: 90 Minutes
IMG Meredith Crabtree
Webinar Id: 62388
Live
Session
$119.00
Single Attendee
$249.00
Group Attendees
Recorded
Session
$159.00
Single Attendee
$359.00
Group Attendees
Combo
Live+Recorded
$249.00
Single Attendee
$549.00
Group Attendees

Overview:

Supply chain resilience is no longer optional-it is a strategic necessity for organizations operating in FDA-regulated industries. In recent years, the pharmaceutical, medical device, and dietary supplement industries have faced unprecedented challenges in maintaining supply chain continuity. From the COVID-19 pandemic to geopolitical instability and supplier quality issues, companies must prepare for a wide range of risks.

This training will explore the critical components of supply chain resilience, including visibility, flexibility, collaboration, and risk management. Participants will learn how to identify and assess supply chain risks using tools like risk matrices and FMEA. The course will cover regulatory expectations for supplier oversight, qualification, and documentation per 21 CFR Parts 211, 820, and other applicable standards.

Real-world case studies will highlight successful responses to API shortages, supplier GMP non-compliance, and demand surges during the COVID-19 pandemic. Best practices for building resilience will include diversification of suppliers, inventory management, leveraging technology for traceability and predictive analytics, and developing robust contingency plans.

Attendees will leave with practical tools and templates for risk assessment, supplier qualification, and continuous improvement to strengthen their organization’s supply chain resilience.

Why you should Attend:

This course offers practical guidance on building resilient supply chains in FDA-regulated industries. Attendees will gain actionable insights into risk identification, supplier qualification, contingency planning, and regulatory expectations. Real-world case studies will demonstrate how leading organizations have successfully navigated supply chain disruptions while maintaining compliance and operational continuity.

Areas Covered in the Session:

  • Introduction to Supply Chain Resilience and Why It Matters
  • Regulatory Expectations for Supplier Oversight and Risk Management
  • Key Components of a Resilient Supply Chain:
    • Visibility
    • Flexibility
    • Collaboration
    • Risk Mitigation
  • Supplier Qualification and Monitoring Best Practices
  • Risk Assessment Tools: FMEA, Risk Matrices, and Is/Is Not Analysis
  • Case Studies:
    • API Shortages and Dual Sourcing
    • Managing Demand Surges in Medical Device Manufacturing
  • Diversification, Inventory Management, and Contingency Planning
  • Leveraging Technology for Traceability and Predictive Analytics
  • Building a Culture of Continuous Improvement

Who Will Benefit:

  • Quality Assurance Managers & Directors
  • Regulatory Affairs Professionals
  • Supply Chain Managers & Directors
  • Compliance Officers
  • Manufacturing & Operations Managers
  • Supplier Quality Managers
  • Procurement Professionals
  • Risk Management Teams

Speaker Profile

Meredith L. Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.